Leaders in HEOR and global market access services
Successfully supporting the healthcare industry for over 20 years
We are DRG Abacus, a Decision Resources Group company formerly known as Abacus International.
Our multi-disciplinary team offers best in class health economics and outcomes research (HEOR) and market access services to the world’s leading pharmaceutical and medical device companies. We balance scientific rigor with commercial awareness, differentiating ourselves from our competition through innovation, technical excellence, and design.
MARKET ACCESS ROADMAP
Early development
Pre-clinical
i Early PHASEPhase I
iPhase II
iMarketing support
Early PHASEPhase III
iRegulatory submissions & launch
i Early PHASELocal market access submissions
iReal world effectiveness
Early PHASEPhase IV Defending the market
iEARLY DEVELOPMENT
MARKETING SUPPORT
REAL WORLD
EFFECTIVENESS
Pre-clinical
- Understand the commercial and clinical opportunities, and market dynamics
- Prepare and plan for clinical development
Strategic
- Commercial evaluation
- Landscape assessments
- Securing R&D investment
Implementation
- Identify unmet need
- Landscape assessments
Phase I
- Commitment to clinical development
- Understand the context, landscape, situation, and early market access strategy development
Strategic
- Target product profiling
- Early pricing and market access strategy development
- Identification of key stakeholders
- PR and publications planning
Implementation
- Evidence review and GAP analysis
- Stakeholder mapping
- Competitor profiling
- Early modelling
Phase II
- Implementation of clinical development
- Generate the evidence: clinical, HEOR, and RWE
Strategic
- Go-No-Go decision to full development
- Define value proposition
- Develop payer evidence strategy
- Outline global market access plan
Implementation
- Early value dossier
- PRO identification
- Validation of clinical outcomes and endpoints
- Economic modelling
Phase III
- Significant investment and further commitment to clinical development
- Ongoing evidence generation
- Global and local implementation of the market access strategy
Strategic
- Confirm the value story
- Pricing research
- Confirm P&MA strategy for key markets
- Competitor profiling
Implementation
- Evidence synthesis including SRs and NMAs
- Database and RWE studies
- Value message testing
- Global economic modelling
- Outcomes research
Regulatory submissions & launch
- Ongoing evidence generation for local markets
- Implementation of the market access strategy
- Communication of the value
Strategic
- Launch sequencing
- Pricing model agreed
- P&R dossier development
- Communication strategy development
- Internal market access capabilities
Implementation
- Global value dossier development
- Global and local evidence generation activities
- Economic modelling
- Publications support
- Market access and HEOR training
Local market access submissions
- Extensive local commercial and clinical preparation
- Coordination of payer and HTA strategy and activity
Strategic
- Country HTA and CER submission strategy
- Development of managed entry agreements
- Coverage with evidence development considerations
Implementation
- Comprehensive HTA submission support
- Local budget impact modelling
- Stakeholder communication tools
- Secondary research market access platform
Phase IV & Defending the Market
- Longer term strategy
- ROI secured
- Value communications
- Expanding and defending listing
Strategic
- Defend value strategies
- Identify growth opportunities
- Line extensions
- New indications
- P&MA strategies
- Respond to delisting and MTAs
Implementation
- Ongoing evidence generation and synthesis (SR, NMA, RWE analysis and outcomes research)
- Global value dossier updates
- Economic modelling updates
- Value communications
- Secondary research market access platforms
To find out more about the market access roadmap service please get in touch
Products and Services
We provide integrated HEOR and market access services to global pharmaceutical product development organisations and medical device companies.
Our Expertise
Our in-house team of strategists, health economists, researchers, medical writers, systematic reviewers, statisticians, designers, developers, and project managers allows you to achieve all aspects of your HEOR and market access goals, eliminating the need to commission several different agencies.
-
ISOQOL 25th Annual Conference, 24 – 27 October Dublin, Ireland
18-09-18DRG AdminISOQOL 25th Annual Conference, 24 – 27 October, Dublin, Ireland We are excited to announce that members of our Clinical Outcomes Assessment (COA) team, in collaboration with our clients have developed tw...
-
ISPOR Europe, 10 – 14 November 2018 Barcelona, Spain
18-09-18DRG AdminAs part of DRG’s Solutions for Global Access, the DRG Abacus team will be bringing the latest insights on topics impacting HEOR and market access professionals on the path to bringing new therapies to pat...
We are part of Decision Resources Group (DRG), a subsidiary of Piramal Enterprises Ltd.
DRG offers best-in-class, high-value data, analytics and insights products and services to the healthcare industry, delivered by more than 1,000 employees across 17 offices in North America, Europe and Asia.
Our Company